摘要
目的:通过325例轻度认知障碍(MCI)、155例AD和185例健康对照,探讨阿尔茨海默病(AD)病理对胼胝体(CC)的影响。方法:采用基于统计形状分析管道的大变形差异测量曲线,对AD诱发的区域特异性形态CC异常进行量化。我们还量化了CC形态表型与两种认知指标的关系:简易精神状态检查(MMSE)和阿尔茨海默病评估量表-认知行为部分(ADAS-COG)。为了识别AD相关区域,CC被划分为三个亚区:属、体和脾(GCC、BCC和SCC).结果:AD组与HC组相比有明显的形态压缩,主要集中在CC的上半部,分布于所有三个亚区。HC-VS-MCI形态异常也集中在上半部,但主要发生在基底细胞癌和鳞状细胞癌。MCI-VS-AD形态差异仅见于部分SCC.在形状认知联想中,GCC和SCC区域的形状变形与ADAS-COg呈显著负相关,以SCC为主的区域与MMSE呈显著正相关。结论:胼胝体变形模式,特别是鳞状细胞癌,与AD的认知功能减退密切相关,是监测AD进展的重要生物标志物。
关键词: 阿尔茨海默病,轻度认知损害,胼胝体,形态分析,变形,形状认知联系。
Current Alzheimer Research
Title:Deformation-based Statistical Shape Analysis of the Corpus Callosum in Mild Cognitive Impairment and Alzheimer’s Disease
Volume: 15 Issue: 12
关键词: 阿尔茨海默病,轻度认知损害,胼胝体,形态分析,变形,形状认知联系。
摘要: Objective: In this study, we investigated the influence that the pathology of Alzheimer’s disease (AD) exerts upon the corpus callosum (CC) using a total of 325 mild cognitive impairment (MCI) subjects, 155 AD subjects, and 185 healthy control (HC) subjects.
Method: Regionally-specific morphological CC abnormalities, as induced by AD, were quantified using a large deformation diffeomorphic metric curve mapping based statistical shape analysis pipeline. We also quantified the association between the CC shape phenotype and two cognitive measures; the Mini Mental State Examination (MMSE) and the Alzheimer’s Disease Assessment Scale-Cognitive Behavior Section (ADAS-cog). To identify AD-relevant areas, CC was sub-divided into three subregions; the genu, body, and splenium (gCC, bCC, and sCC).
Results: We observed significant shape compressions in AD relative to that in HC, mainly concentrated on the superior part of CC, across all three sub-regions. The HC-vs-MCI shape abnormalities were also concentrated on the superior part, but mainly occurred on bCC and sCC. The significant MCI-vs-AD shape differences, however, were only detected in part of sCC. In the shape-cognition association, significant negative correlations to ADAS-cog were detected for shape deformations at regions belonging to gCC and sCC and significant positive correlations to MMSE at regions mainly belonging to sCC.
Conclusion: Our results suggest that the callosal shape deformation patterns, especially those of sCC, linked tightly to the cognitive decline in AD, and are potentially a powerful biomarker for monitoring the progression of AD.
Export Options
About this article
Cite this article as:
Deformation-based Statistical Shape Analysis of the Corpus Callosum in Mild Cognitive Impairment and Alzheimer’s Disease, Current Alzheimer Research 2018; 15 (12) . https://dx.doi.org/10.2174/1567205015666180813145935
DOI https://dx.doi.org/10.2174/1567205015666180813145935 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Conference Report (The XVth International Symposium of Brain Edema and Cellular Injury)
CNS & Neurological Disorders - Drug Targets Current In Vitro High Throughput Screening Approaches to Assess Nuclear Receptor Activation
Current Drug Metabolism Alcoholism and its Effects on the Central Nervous System
Current Neurovascular Research Top-Down Versus Bottom-Up Nanoengineering Routes to Design Advanced Oropharmacological Products
Current Pharmaceutical Design Mitogen Activated Protein (MAP) Kinases: Development of ATP and Non- ATP Dependent Inhibitors
Medicinal Chemistry Effect of Doxycycline on Atherosclerosis: From Bench to Bedside
Recent Patents on Cardiovascular Drug Discovery Author Index to Volume 1
Current Neurovascular Research Serotonin Type-4 (5-HT4) Receptors as Therapeutic Targets: Past and Future Roles of 5-HT4 Receptor Agonists
Current Medicinal Chemistry - Central Nervous System Agents Exploring the Role of Gene Therapy for Neurological Disorders
Current Gene Therapy Conversion of Benzimidazoles, Imidazothiazoles and Imidazoles into more Potent Central Nervous System Acting Drugs
Central Nervous System Agents in Medicinal Chemistry Editorial [Hot Topic: Protective or Damaging Immunity in Infection (Guest Editors: Jose Gutierrez and Antonio Sorlozano)]
Current Immunology Reviews (Discontinued) Patent Selections:
Recent Patents on CNS Drug Discovery (Discontinued) Mechanisms of Platelet Activation in Acute Coronary Syndromes
Current Vascular Pharmacology Pharmacologic Strategies for Suppression of Lipid Peroxidation in Neurodegeneration
Current Neuropharmacology Chemical and Pharmacological Aspects of Heteroaryl-Nitrones
Current Medicinal Chemistry Anticancer Agents: Towards the Future
Current Medicinal Chemistry - Anti-Cancer Agents Recent Advances in Metabolic Profiling and Imaging of Prostate Cancer
Current Metabolomics Nutrigenomics and Personalized Diet: What are the Anticipated Impacts for Research on Chronic Diseases and Public Health?
Current Pharmacogenomics and Personalized Medicine Meet Our Editorial Board Member
CNS & Neurological Disorders - Drug Targets Best Practice for Atrial Fibrillation Patient Education
Current Pharmaceutical Design